Filter News
Area of Research
- (-) Advanced Manufacturing (1)
- (-) National Security (3)
- (-) Neutron Science (5)
- (-) Quantum information Science (3)
- Biological Systems (1)
- Biology and Environment (1)
- Clean Energy (14)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (8)
- Materials (4)
- Supercomputing (25)
News Topics
- (-) Bioenergy (2)
- (-) Biomedical (2)
- (-) Computer Science (8)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (4)
- Artificial Intelligence (1)
- Big Data (1)
- Clean Water (1)
- Composites (1)
- Cybersecurity (4)
- Energy Storage (3)
- Environment (4)
- Fusion (2)
- Grid (2)
- Machine Learning (2)
- Materials Science (5)
- Microscopy (1)
- Neutron Science (18)
- Nuclear Energy (12)
- Physics (3)
- Quantum Science (4)
- Space Exploration (2)
- Sustainable Energy (1)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.